Laporan Laba Rugi (TTM)
Laporan Laba Rugi Y-mAbs Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 26 | 37 | 46 | 35 | 40 | 40 | 43 | 65 | 75 | 85 | 93 | 85 | 84 | 87 | 85 | 88 | 89 | 85 |
| Change (%) | 25.94 | 41.90 | 24.17 | -24.22 | 14.62 | -0.39 | 8.96 | 50.32 | 14.96 | 13.27 | 9.32 | -8.70 | -0.38 | 2.42 | -2.30 | 3.70 | 1.11 | -3.69 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 2 | 3 | 3 | 3 | 4 | 5 | 7 | 8 | 8 | 11 | 11 | 11 | 11 | 10 | 9 | 15 | 16 | 16 |
| Change (%) | 4.22 | 17.86 | 20.33 | -22.79 | 69.13 | 19.54 | 37.87 | 7.98 | 3.33 | 43.59 | 1.51 | 0.17 | 0.56 | -14.24 | -4.03 | 61.42 | 5.60 | -1.88 | |
| % of Revenue | 10.62 | 8.79 | 7.30 | 7.07 | 7.20 | 10.63 | 12.76 | 16.14 | 11.59 | 10.42 | 13.21 | 12.27 | 13.46 | 13.59 | 11.38 | 11.17 | 17.39 | 18.17 | 18.51 |
| Gross Operating Profit | 19 | 24 | 34 | 43 | 32 | 36 | 35 | 36 | 58 | 67 | 74 | 82 | 73 | 73 | 77 | 75 | 72 | 73 | 70 |
| Change (%) | 28.52 | 44.22 | 24.48 | -24.33 | 10.39 | -2.76 | 4.74 | 58.47 | 16.49 | 9.74 | 10.50 | -9.94 | -0.52 | 5.04 | -2.08 | -3.56 | 0.16 | -4.09 | |
| % of Revenue | 89.38 | 91.21 | 92.70 | 92.93 | 92.80 | 89.37 | 87.24 | 83.86 | 88.41 | 89.58 | 86.79 | 87.73 | 86.54 | 86.41 | 88.62 | 88.83 | 82.61 | 81.83 | 81.49 |
| SG&A | 46 | 50 | 54 | 56 | 57 | 58 | 57 | 57 | 52 | 50 | 48 | 44 | 44 | 45 | 51 | 50 | 50 | 51 | 45 |
| Change (%) | 9.39 | 7.06 | 4.94 | 0.94 | 2.67 | -2.08 | -0.50 | -7.88 | -5.10 | -2.84 | -8.11 | 0.11 | 0.44 | 13.35 | -2.17 | 1.14 | 2.27 | -12.70 | |
| % of Revenue | 221.20 | 192.12 | 144.95 | 122.49 | 163.16 | 146.14 | 143.66 | 131.18 | 80.39 | 66.36 | 56.92 | 47.85 | 52.46 | 52.89 | 58.54 | 58.62 | 57.17 | 57.83 | 52.42 |
| R&D | 93 | 95 | 84 | 86 | 91 | 92 | 99 | 98 | 89 | 76 | 62 | 56 | 50 | 53 | 54 | 49 | 47 | 45 | 43 |
| Change (%) | 2.69 | -11.30 | 2.16 | 5.48 | 1.41 | 7.15 | -0.76 | -9.64 | -14.10 | -18.26 | -10.61 | -9.87 | 6.61 | 0.52 | -7.82 | -4.19 | -4.87 | -4.81 | |
| % of Revenue | 446.18 | 363.82 | 227.41 | 187.10 | 260.42 | 230.40 | 247.82 | 225.70 | 135.67 | 101.38 | 73.16 | 59.83 | 59.06 | 63.20 | 62.03 | 58.52 | 54.07 | 50.87 | 50.29 |
| OpEx | 141 | 148 | 141 | 146 | 150 | 155 | 161 | 162 | 149 | 134 | 122 | 111 | 106 | 110 | 114 | 108 | 113 | 112 | 103 |
| Change (%) | 4.90 | -4.60 | 3.57 | 3.09 | 3.02 | 4.01 | 0.55 | -8.26 | -10.04 | -8.90 | -8.50 | -4.86 | 3.37 | 4.21 | -4.98 | 3.96 | -0.28 | -7.98 | |
| % of Revenue | 678.00 | 564.73 | 379.65 | 316.66 | 430.78 | 387.17 | 404.24 | 373.02 | 227.66 | 178.16 | 143.30 | 119.94 | 124.98 | 129.68 | 131.94 | 128.32 | 128.64 | 126.87 | 121.21 |
| Operating Income | -120 | -121 | -104 | -100 | -115 | -115 | -121 | -119 | -83 | -59 | -37 | -19 | -21 | -25 | -28 | -24 | -25 | -24 | -18 |
| Change (%) | 1.26 | -14.61 | -3.80 | 15.70 | -0.49 | 5.54 | -2.22 | -29.71 | -29.62 | -37.26 | -49.65 | 14.37 | 18.35 | 10.23 | -13.38 | 4.86 | -5.13 | -23.96 | |
| % of Revenue | -578.00 | -464.73 | -279.65 | -216.66 | -330.78 | -287.17 | -304.24 | -273.02 | -127.66 | -78.16 | -43.30 | -19.94 | -24.98 | -29.68 | -31.94 | -28.32 | -28.64 | -26.87 | -21.21 |
| Interest Expense | -1 | -1 | -1 | -2 | -2 | -3 | -4 | ||||||||||||
| Change (%) | 32.24 | -3.17 | 63.60 | 1.89 | 50.87 | 47.59 | |||||||||||||
| % of Revenue | -3.38 | -3.15 | -2.46 | -5.31 | -4.72 | -7.15 | -9.68 | ||||||||||||
| Net Income | -119 | -60 | -42 | -38 | -55 | -117 | -135 | -134 | -96 | -74 | -39 | -19 | -21 | -22 | -25 | -24 | -30 | -28 | -22 |
| Change (%) | -49.94 | -29.22 | -9.40 | 44.26 | 111.23 | 15.58 | -0.99 | -28.48 | -22.68 | -47.14 | -50.64 | 11.12 | 1.12 | 13.60 | -3.04 | 24.31 | -4.83 | -21.28 | |
| % of Revenue | -575.12 | -228.62 | -114.04 | -83.20 | -158.39 | -291.89 | -338.68 | -307.75 | -146.43 | -98.48 | -45.96 | -20.75 | -25.26 | -25.64 | -28.44 | -28.22 | -33.83 | -31.84 | -26.03 |
Source: Capital IQ
